Celtaxsys, Inc. Appoints Khalil Barrage to Board of Directors
4/19/2013 7:46:33 AM
More...
|
Celtaxsys, Inc. Initiates Phase 1 Study of CTX-4430 Oral Treatment for Pulmonary Inflammation
1/3/2013 9:49:44 AM
More...
|
Brett Premack, Ph.D. Joins Celtaxsys, Inc. as Chief Technology Officer
10/24/2012 8:50:19 AM
More...
|
Celtaxsys, Inc. Acquires Clinical Stage Innate Immunity Drug for Inflammation
1/5/2012 3:01:59 PM
More...
|
Dr. H. Daniel Perez Joins Celtaxsys, Inc. Board of Directors
6/6/2011 1:25:00 PM
More...
|
Dr. Michael Hanley Joins Celtaxsys, Inc. as CEO
12/3/2010 7:09:34 AM
More...
|
Celtaxsys, Inc. Seeks $10 Million to Develop Immune System Drugs; Raises $4.2 Million So Far
11/5/2010 6:54:10 AM
More...
|
Celtaxsys, Inc. Hires Eric B. Springman, Ph.D. to the Position of Chief Scientific Officer
12/10/2009 11:33:24 AM
More...
|